Functional Alternatives to Alcohol.

Autor: Nutt DJ; GABA Labs (Research) Ltd., Old Town Court, 70 Queensway, Suite 2, Hemel Hempstead HP2 5HD, UK., Tyacke RJ; GABA Labs (Research) Ltd., Old Town Court, 70 Queensway, Suite 2, Hemel Hempstead HP2 5HD, UK., Spriggs M; GABA Labs (Research) Ltd., Old Town Court, 70 Queensway, Suite 2, Hemel Hempstead HP2 5HD, UK., Jacoby V; GABA Labs (Research) Ltd., Old Town Court, 70 Queensway, Suite 2, Hemel Hempstead HP2 5HD, UK., Borthwick AD; GABA Labs (Research) Ltd., Old Town Court, 70 Queensway, Suite 2, Hemel Hempstead HP2 5HD, UK., Belelli D; GABA Labs (Research) Ltd., Old Town Court, 70 Queensway, Suite 2, Hemel Hempstead HP2 5HD, UK.

Publikováno v: Nutrients [Nutrients] 2022 Sep 13; Vol. 14 (18). Date of Electronic Publication: 2022 Sep 13.

Corrigendum to "Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury" [Bioorg. Med. Chem. Lett. 29(8) (2019) 995-1000].

Autor: Goncalves MB; Neuroscience Drug Discovery Unit, Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College, London SE1 1UL, UK., Clarke E; Neuroscience Drug Discovery Unit, Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College, London SE1 1UL, UK., Jarvis CI; Neuroscience Drug Discovery Unit, Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College, London SE1 1UL, UK., Kalindjian SB; Neuroscience Drug Discovery Unit, Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College, London SE1 1UL, UK., Pitcher T; Neuroscience Drug Discovery Unit, Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College, London SE1 1UL, UK., Grist J; Neuroscience Drug Discovery Unit, Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College, London SE1 1UL, UK., Hobbs C; Neuroscience Drug Discovery Unit, Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College, London SE1 1UL, UK., Carlstedt T; Neuroscience Drug Discovery Unit, Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College, London SE1 1UL, UK., Jack J; Neuroscience Drug Discovery Unit, Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College, London SE1 1UL, UK., Brown JT; Sygnature Discovery Limited, Biocity, Pennyfoot Street, Nottingham NG1 1GF, UK., Mills M; Sygnature Discovery Limited, Biocity, Pennyfoot Street, Nottingham NG1 1GF, UK., Mumford P; Sygnature Discovery Limited, Biocity, Pennyfoot Street, Nottingham NG1 1GF, UK., Borthwick AD; DrugMolDesign, 15 Temple Grove, London NW11 7UA, UK. Electronic address: alan.d.borthwick@drugmoldesign.com., Corcoran JPT; Neuroscience Drug Discovery Unit, Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College, London SE1 1UL, UK. Electronic address: jonathan.corcoran@kcl.ac.uk.

Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2019 Aug 15; Vol. 29 (16), pp. 2440-2441. Date of Electronic Publication: 2019 Jun 14.

Design and synthesis of a potent, highly selective, orally bioavailable, retinoic acid receptor alpha agonist.

Autor: Clarke E; Neuroscience Drug Discovery Unit, Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College, London SE1 1UL, UK., Jarvis CI; Neuroscience Drug Discovery Unit, Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College, London SE1 1UL, UK., Goncalves MB; Neuroscience Drug Discovery Unit, Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College, London SE1 1UL, UK., Kalindjian SB; Neuroscience Drug Discovery Unit, Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College, London SE1 1UL, UK., Adams DR; Sygnature Discovery Limited, Biocity, Pennyfoot Street, Nottingham NG1 1GF, UK., Brown JT; Sygnature Discovery Limited, Biocity, Pennyfoot Street, Nottingham NG1 1GF, UK., Shiers JJ; Sygnature Discovery Limited, Biocity, Pennyfoot Street, Nottingham NG1 1GF, UK., Taddei DMA; Sygnature Discovery Limited, Biocity, Pennyfoot Street, Nottingham NG1 1GF, UK., Ravier E; Sygnature Discovery Limited, Biocity, Pennyfoot Street, Nottingham NG1 1GF, UK., Barlow S; Sygnature Discovery Limited, Biocity, Pennyfoot Street, Nottingham NG1 1GF, UK., Miller I; Sygnature Discovery Limited, Biocity, Pennyfoot Street, Nottingham NG1 1GF, UK., Smith V; Sygnature Discovery Limited, Biocity, Pennyfoot Street, Nottingham NG1 1GF, UK., Borthwick AD; DrugMolDesign, 15 Temple Grove, London NW11 7UA, UK. Electronic address: alan.d.borthwick@drugmoldesign.com., Corcoran JPT; Neuroscience Drug Discovery Unit, Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College, London SE1 1UL, UK.

Publikováno v: Bioorganic & medicinal chemistry [Bioorg Med Chem] 2018 Feb 15; Vol. 26 (4), pp. 798-814. Date of Electronic Publication: 2017 Dec 09.

2,5-diketopiperazines in food and beverages: Taste and bioactivity.

Autor: Borthwick AD; a DrugMolDesign , London , United Kingdom., Da Costa NC; b International Flavors & Fragrances, Inc. , Union Beach , New Jersey , USA.

Publikováno v: Critical reviews in food science and nutrition [Crit Rev Food Sci Nutr] 2017 Mar 04; Vol. 57 (4), pp. 718-742.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.